Allen Investment Management LLC Buys New Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

Allen Investment Management LLC acquired a new position in LifeStance Health Group, Inc. (NASDAQ:LFST) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 12,873 shares of the company’s stock, valued at approximately $79,000.

Several other hedge funds have also bought and sold shares of the stock. Assetmark Inc. boosted its position in LifeStance Health Group by 21.6% in the 4th quarter. Assetmark Inc. now owns 11,895 shares of the company’s stock worth $93,000 after purchasing an additional 2,114 shares in the last quarter. SG Americas Securities LLC boosted its position in LifeStance Health Group by 8.7% in the 1st quarter. SG Americas Securities LLC now owns 44,925 shares of the company’s stock worth $277,000 after purchasing an additional 3,600 shares in the last quarter. Sunbelt Securities Inc. acquired a new position in shares of LifeStance Health Group during the 3rd quarter worth approximately $34,000. Charles Schwab Investment Management Inc. raised its stake in shares of LifeStance Health Group by 0.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 744,617 shares of the company’s stock worth $5,830,000 after buying an additional 5,112 shares during the period. Finally, Stratos Wealth Partners LTD. acquired a new position in shares of LifeStance Health Group during the 4th quarter worth approximately $93,000. Hedge funds and other institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Stock Performance

Shares of LFST stock traded down $0.16 during trading hours on Friday, hitting $5.33. 1,530,601 shares of the company’s stock were exchanged, compared to its average volume of 1,279,334. The firm has a 50 day moving average of $5.80 and a two-hundred day moving average of $6.33. LifeStance Health Group, Inc. has a fifty-two week low of $4.64 and a fifty-two week high of $9.52. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.20.

LifeStance Health Group (NASDAQ:LFST) last released its earnings results on Thursday, May 9th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.03. The business had revenue of $300.44 million during the quarter, compared to analyst estimates of $299.02 million. LifeStance Health Group had a negative net margin of 15.69% and a negative return on equity of 11.92%. The company’s revenue for the quarter was up 18.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.09) earnings per share. On average, equities research analysts predict that LifeStance Health Group, Inc. will post -0.26 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Morgan Stanley reaffirmed an “overweight” rating and set a $10.00 target price on shares of LifeStance Health Group in a research note on Monday, April 22nd. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, LifeStance Health Group presently has an average rating of “Hold” and an average price target of $8.80.

Insider Buying and Selling at LifeStance Health Group

In other news, major shareholder Summit Partners Growth Equity sold 3,802,345 shares of the company’s stock in a transaction that occurred on Friday, May 24th. The stock was sold at an average price of $5.89, for a total value of $22,395,812.05. Following the completion of the sale, the insider now directly owns 41,932,358 shares in the company, valued at $246,981,588.62. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, insider Paula Cipollone sold 48,278 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $7.22, for a total value of $348,567.16. Following the completion of the sale, the insider now directly owns 239,915 shares in the company, valued at $1,732,186.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Summit Partners Growth Equity sold 3,802,345 shares of the company’s stock in a transaction that occurred on Friday, May 24th. The shares were sold at an average price of $5.89, for a total value of $22,395,812.05. Following the completion of the sale, the insider now owns 41,932,358 shares of the company’s stock, valued at $246,981,588.62. The disclosure for this sale can be found here. In the last quarter, insiders sold 4,087,716 shares of company stock worth $24,010,444. Insiders own 6.60% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.